Clinical Outcomes and Virulence Factors of Shiga Toxin-Producing Escherichia coli (STEC) from Southern Alberta, Canada, from 2020 to 2022
Pathogens · 2024
DOI: 10.3390/pathogens13100822 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Heather Glassman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2R3, Canada. Hauptthemen laut MEDLINE: Virulence Factors, Shiga-Toxigenic Escherichia coli, Escherichia coli Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Shiga toxin-producing Escherichia coli (STEC) can cause severe clinical disease in humans, particularly in young children. Recent advances have led to greater availability of sequencing technologies. We sought to use whole genome sequencing data to identify the presence or absence of known virulence factors in all clinical isolates submitted to our laboratory from Southern Alberta dated 2020–2022 and correlate these virulence factors with clinical outcomes obtained through chart review. Overall, the majority of HUS and hospitalizations were seen in patients with O157:H7 serotypes, and HUS cases were primarily in young children. The frequency of virulence factors differed between O157:H7 and non-O157 serotypes. Within the O157:H7 cases, certain virulence factors, including espP, espX1, and katP, were more frequent in HUS cases. The number of samples was too low to determine statistical significance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2R3, Canada.
- Medical Officer of Health, Alberta Health Services, Lethbridge, AB T1J 4E1, Canada.
- Environmental Public Health, South Zone, Alberta Health Services, Taber, AB T1G 1N9, Canada.
- National Microbiology Laboratory at Guelph, Public Health Agency of Canada, Guelph, ON N1G 3W4, Canada.
- National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3C 4W1, Canada.
- Alberta Precision Laboratories-Public Health Laboratory, Edmonton, AB T6G 2J2, Canada.
ORCID-Profile: Linda Chui
Zitieren
APA
Glassman, H., Suttorp, V., White, T., Ziebell, K., Kearney, A., Bessonov, K., Li, V., & Chui, L. (2024). Clinical Outcomes and Virulence Factors of Shiga Toxin-Producing Escherichia coli (STEC) from Southern Alberta, Canada, from 2020 to 2022. Pathogens. https://doi.org/10.3390/pathogens13100822
Vancouver
Glassman H, Suttorp V, White T, Ziebell K, Kearney A, Bessonov K, et al. Clinical Outcomes and Virulence Factors of Shiga Toxin-Producing Escherichia coli (STEC) from Southern Alberta, Canada, from 2020 to 2022. Pathogens. 2024. doi:10.3390/pathogens13100822
BibTeX
@article{Glassman2024,
author = {Glassman, Heather and Suttorp, Vivien and White, Theron and Ziebell, Kim and Kearney, Ashley and Bessonov, Kyrylo and Li, Vincent and Chui, Linda},
title = {Clinical Outcomes and Virulence Factors of Shiga Toxin-Producing Escherichia coli (STEC) from Southern Alberta, Canada, from 2020 to 2022},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13100822}
}
EUVIMED